LivaNova PLC Business Combination, Acquisition Related Costs
LivaNova PLC (LIVN) reported Business Combination, Acquisition Related Costs of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2022-05-04
- LivaNova PLC business combination, acquisition related costs for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- LivaNova PLC business combination, acquisition related costs for the quarter ending 2020-12-31 was $0.00.
- LivaNova PLC business combination, acquisition related costs for the quarter ending 2020-09-30 was $0.00.
- LivaNova PLC business combination, acquisition related costs for the quarter ending 2020-06-30 was $0.00.
- LivaNova PLC business combination, acquisition related costs for fiscal 2020 was $0.00.
- LivaNova PLC business combination, acquisition related costs for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- LivaNova PLC business combination, acquisition related costs for fiscal 2018 was $24.42M, a 57.26% increase from fiscal 2017.
- LivaNova PLC business combination, acquisition related costs for fiscal 2017 was $15.53M, a 23.80% decline from fiscal 2016.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 3 month as first filed | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 8 month | Business Combination, Acquisition Related Costs 8 month as first filed | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month | Business Combination, Acquisition Related Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $630.00K 10-Q · filed 2021-04-28 | $0.00 derived: sum of 2 quarters · filed 2022-05-04 | $0.00 derived: sum of 3 quarters · filed 2022-05-04 | $0.00 derived: sum of 4 quarters · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | $7.33M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | |||||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-28 | $0.00 10-Q · filed 2021-07-28 | ||||||
| 2020-03-31 | $3.47M 10-Q · filed 2021-04-28 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | $23.46M 10-K · filed 2020-03-02 | ||||||
| 2018-12-31 | $24.42M 10-K · filed 2021-03-01 | |||||||
| 2017-12-31 | $15.53M 10-K · filed 2020-03-02 | |||||||
| 2016-12-31 | $20.38M 10-K · filed 2019-03-18 | $20.54M 10-K · filed 2017-03-01 | ||||||
| 2016-03-31 | $6.76M 10-Q · filed 2016-05-09 | |||||||
| 2015-12-31 | $55.78M 10-K · filed 2018-02-28 | $42.10M 10-KT · filed 2016-03-04 | ||||||
| 2015-10-18 | $27.90M 10-Q · filed 2015-12-08 | $34.45M 10-Q · filed 2015-12-08 | ||||||
| 2015-04-24 | $8.69M 10-Q · filed 2016-05-09 | $8.69M 10-K · filed 2018-02-28 | ||||||
| 2014-12-26 | $0.00 10-K · filed 2018-02-28 | |||||||
| 2014-10-24 | $0.00 10-Q · filed 2015-12-08 | $0.00 10-Q · filed 2015-12-08 | ||||||
| 2014-04-25 | $0.00 10-K · filed 2017-03-01 | |||||||
| 2013-04-26 | $0.00 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |